Myelodysplastic Syndromes, Version 2.2017, NCCN Clinical Practice Guidelines in OncologyPeter L. Greenberg, Courtney Smith, Mark Juckett et al.|Journal of the National Comprehensive Cancer Network|2016Cited by 297
Omidubicel vs standard myeloablative umbilical cord blood transplantation: results of a phase 3 randomized studyMitchell E. Horwitz, Guillermo Sanz, Patrick J. Stiff et al.|Blood|2021Cited by 110
Myelodysplastic Syndromes, Version 2.2015Peter L. Greenberg, Courtney Smith, Richard M. Stone et al.|Journal of the National Comprehensive Cancer Network|2015Cited by 54
Heritable GATA2 mutations associated with familial AML-MDS: a case report and review of literatureJuehua Gao, LoAnn Peterson, Ryan D. Gentzler et al.|Journal of Hematology & Oncology|2014Cited by 31
Open-Label Phase II Prospective, Randomized, Controlled Study of Romyelocel-L Myeloid Progenitor Cells to Reduce Infection During Induction Chemotherapy for Acute Myeloid LeukemiaPinkal Desai, Farhad Ravandi, J. Martin Brown et al.|Journal of Clinical Oncology|2021Cited by 21